Utama › Limfoma Burkitt › Missouri › Kansas City
Kajian klinikal Limfoma Burkitt di Kansas City, MO
10 kajian untuk Limfoma Burkitt sedang mencari peserta di lokasi dalam dan sekitar Kansas City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene
Mengambil pesertaFasa 1/2
- University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi jauh
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
Mengambil pesertaFasa 2
- University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi jauh
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Mengambil pesertaFasa 2
- Children's Mercy Hospitals and Clinics, Kansas City
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Mengambil pesertaFasa 1/2
- Children's Mercy Hospital ( Site 1024), Kansas City
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Mengambil pesertaFasa 3
- University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi jauh
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Mengambil pesertaFasa 2
- Children's Mercy Hospitals and Clinics, Kansas City
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Mengambil pesertaFasa 2
- Children's Mercy Hospitals and Clinics, Kansas City
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Mengambil pesertaFasa 3
- Children's Mercy Hospitals and Clinics, Kansas City
Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies
Mengambil pesertaFasa 1
- University of Kansas Cancer Center, Westwood · 5 mi jauh
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
Mengambil pesertaFasa 2
- Children's Mercy Hospital, Kansas City
Kajian Limfoma Burkitt di bandar lain
- Houston, TX21 kajian
- Milwaukee, WI16 kajian
- Philadelphia, PA16 kajian
- Chicago, IL15 kajian
- New York City, NY13 kajian
- Cincinnati, OH13 kajian
- Atlanta, GA12 kajian
- Seattle, WA11 kajian
- Aurora, CO11 kajian
- Boston, MA10 kajian
- Los Angeles, CA10 kajian
- Durham, NC10 kajian
Kajian lain di Kansas City
- Kanser Payudara34 kajian
- Kanser Paru-paru Bukan Sel Kecil31 kajian
- Kegagalan Jantung25 kajian
- Kanser (semua jenis)22 kajian
- Kanser Paru-paru19 kajian
- Kanser Kolorektal16 kajian
- Kanser Metastatik15 kajian
- Leukemia Mieloid Akut15 kajian
- Kanser Prostat14 kajian
- Kanser Ovari12 kajian
- Diabetes Jenis 211 kajian
- Obesiti11 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 7 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.